Results 111 to 120 of about 278,985 (182)

Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight. [PDF]

BMC Endocr Disord
Caprio S, Pilli T, Cantara S, Sestini F, Fioravanti C, Ciuoli C, Dalmiglio C, Corbo A, Castagna MG.   +8 more
europepmc   +1 more source

DRD4 gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease. [PDF]

Ann Clin Transl Neurol
Torres V, Pérez-Montesino J, Fernández-Santiago R, Fernández M, Camara A, Compta Y, Martí MJ, Guerra Beltran À, Rios J, Valldeoriola F, Ezquerra M.   +10 more
europepmc   +1 more source

Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson's Disease. [PDF]

Brain Sci
Crispo JAG, Farhat N, Fortin Y, Perez-Lloret S, Sikora L, Morgan RL, Habash M, Gogna P, Kelly SE, Elliott J, Kohen DE, Bjerre LM, Mattison DR, Hessian RC, Willis AW, Krewski D.   +15 more
europepmc   +1 more source

Chronic dizziness in restless legs syndrome (RLS) patients responsive to levodopa or dopamine agonists. [PDF]

BMJ Case Rep
Prakash S, Patel H, Shah CS, Prakash A.
europepmc   +1 more source

Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center. [PDF]

Pituitary
Prencipe N, Bona C, Cuboni D, Berton AM, Bioletto F, Varaldo E, Aversa LS, Sibilla M, Gasco V, Ghigo E, Grottoli S.   +10 more
europepmc   +1 more source

A Comprehensive Review of the Efficacy and Safety of Dopamine Agonists for Women with Endometriosis-associated Infertility from Inception to July 31, 2022. [PDF]

Acta Med Philipp
Estole-Casanova LA.
europepmc   +1 more source